Pressmeddelanden, rapporter och bolagsmeddelande för Dancann Pharma
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S Completes Issuance (8) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S delivers annual shareholder letter and investor update
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Flagging announcement
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S publishes Q3-2023 report
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S publishes Q3-2023 report
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S Completes Issuance (7) of New Shares under the Loan-Agreement with Nordic Growth Opportunities 2 - Marking a Milestone with a Conversion Rate Exceeding 50 percent of Tranche 1
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S Completes Issuance (6) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S: Future strategic direction
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S Completes Issuance (5) of New Shares from Debt Conversion under the 10-Year Financing Loan-Agreement with 12-months Conversion Option with Nordic Growth Opportunities 2
Spotlight News
Nyhetsuppdatering från Dancann Pharma
Press release from Companies: DanCann Pharma A/S sigter mod at accelerere forretnings- og indtægtsvækst: Omfattende strategiopdatering følger i oktober